Literature DB >> 9075789

Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.

Y Nakanishi1, A Ochiai, S Akimoto, H Kato, H Watanabe, Y Tachimori, S Yamamoto, S Hirohashi.   

Abstract

It has been suggested that inactivation of the cadherin-mediated cell-cell adhesion system plays a role in the initial steps of cancer invasion and metastasis. Expression of E-cadherin and its intracytoplasmic binding molecules, alpha-catenin, beta-catenin and plakoglobin was examined immunohistochemically in 96 esophageal squamous cell carcinomas to investigate the association between their expression and the prognosis for patients with esophageal cancer. Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression was observed in 44, 72, 73 and 88% of the tumors, respectively. Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05). Downregulation of alpha-catenin was associated with a poor prognosis in patients with esophageal squamous cell carcinoma (p < 0.05). This result suggests that downregulation of alpha-catenin, which may reflect dysfunction of the cadherin-mediated cell-cell adhesion system, is a factor indicating a poor prognosis in patients with esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075789     DOI: 10.1159/000227681

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  37 in total

1.  Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  M J Pukkila; J A Virtaniemi; E J Kumpulainen; R T Pirinen; R T Johansson; H J Valtonen; M T Juhola; V M Kosma
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma.

Authors:  R Amitay; D Nass; D Meitar; I Goldberg; B Davidson; L Trakhtenbrot; F Brok-Simoni; A Ben-Ze'ev; G Rechavi; Y Kaufmann
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu-Feng Cao; Lv Ji; Bin Zhu; Lei Tao; Dong-dong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

4.  The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.

Authors:  Kai Liu; Yue Luo; Hui Tian; Kai-Zhong Yu; Jin-Xian He; Wei-Yu Shen
Journal:  Tumour Biol       Date:  2014-02

5.  Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.

Authors:  R T Pirinen; P Hirvikoski; R T Johansson; S Hollmén; V M Kosma
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

6.  Temporal modulation of β-catenin signaling by multicellular aggregation kinetics impacts embryonic stem cell cardiomyogenesis.

Authors:  Melissa A Kinney; Carolyn Y Sargent; Todd C McDevitt
Journal:  Stem Cells Dev       Date:  2013-06-14       Impact factor: 3.272

7.  Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.

Authors:  Ying-Cheng Lin; Ming-Yao Wu; De-Rui Li; Xian-Ying Wu; Rui-Ming Zheng
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.

Authors:  Xi-Jiang Zhao; Hui Li; Hua Chen; Yan-Xue Liu; Li-Hua Zhang; Su-Xiang Liu; Qing-Lai Feng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.

Authors:  Tsuyoshi Saito; Hiroyuki Mitomi; Abdukadir Imamhasan; Takuo Hayashi; Keiko Mitani; Michiko Takahashi; Yoshiaki Kajiyama; Takashi Yao
Journal:  Virchows Arch       Date:  2014-01-26       Impact factor: 4.064

Review 10.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.